Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

18.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
18.7K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

10.2K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
10.2K
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

4.0K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of Hi-C sequencing to detect oncogene rearrangements for diagnosis and treatment of large B-cell lymphoma.

Blood advances·2026
Same author

Improved survival with fludarabine-based therapies in mixed phenotype acute leukaemia: A population-based study using the WHO 2022 classification.

British journal of haematology·2026
Same author

Engineered GM1 Intersects Between Mitochondrial and Synaptic Pathways to Ameliorate ALS Pathology.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis.

Blood advances·2025
Same author

Proteomic Study of Diffuse Large B-Cell Lymphoma Identifying Proteins Associated with R-CHOP Response.

Biomedicines·2025
Same author

Mu-opioid receptor availability in patients with opioid use disorder treated with either methadone or buprenorphine.

medRxiv : the preprint server for health sciences·2025

Related Experiment Video

Updated: Apr 15, 2026

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

12.9K

Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis.

Karen Dybkær1, Martin Bøgsted1, Steffen Falgreen1

  • 1Karen Dybkær, Martin Bøgsted, Steffen Falgreen, Julie S. Bødker, Malene K. Kjeldsen, Alexander Schmitz, Anders E. Bilgrau, Kim S. Bergkvist, Maria B. Laursen, Maria Rodrigo-Domingo, Sara C. Marques, Sophie B. Rasmussen, Mette Nyegaard, Michael Gaihede, Preben Johansen, Tarec C. El-Galaly, and Hans E. Johnsen, Aalborg University Hospital; Karen Dybkær, Martin Bøgsted, Anders E. Bilgrau, Maria Rodrigo-Domingo, Michael Gaihede, and Hans E. Johnsen, Aalborg University, Aalborg; Michael B. Møller, Odense University Hospital, Odense, Denmark; Zijun Y. Xu-Monette, Ling Li, and Ken H. Young, The University of Texas MD Anderson Cancer Center, Houston, TX; and Richard J. Samworth and Rajen D. Shah, University of Cambridge, Cambridge, United Kingdom.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|March 25, 2015
PubMed
Summary

New B-cell-associated gene signatures (BAGS) offer refined classification for diffuse large B-cell lymphoma, improving diagnostic and prognostic insights. This gene signature approach enhances understanding of B-cell subtypes and their impact on patient outcomes.

More Related Videos

Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

19.4K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.3K

Related Experiment Videos

Last Updated: Apr 15, 2026

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

12.9K
Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

19.4K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.3K

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Current diffuse large B-cell lymphoma (DLBCL) diagnostics rely on the heterogeneous WHO criteria.
  • A need exists for refined classification systems offering deeper biologic insight and prognostic value.

Purpose of the Study:

  • To develop and validate a novel classification system for DLBCL using B-cell-associated gene signatures (BAGS).
  • To assess the diagnostic and prognostic utility of BAGS-defined B-cell subsets in DLBCL.
  • To explore potential correlations between BAGS subtypes and therapeutic response.

Main Methods:

  • Generation of BAGS for normal B-cell hierarchy subsets (naive, centrocyte, centroblast, memory, plasmablast) using fluorescence-activated cell sorting and gene expression profiling.
  • Analysis of BAGS-assigned subtyping across five clinical cohorts (n=1,139) including patients treated with CHOP and R-CHOP chemotherapy.
  • Estimation of subtype frequencies, drug-specific resistance, and prognostic meta-analysis for R-CHOP treated patients.

Main Results:

  • BAGS demonstrated consistent subtype frequencies across diverse cohorts.
  • BAGS assignment significantly correlated with overall and progression-free survival in R-CHOP treated patients, with the centrocyte subtype showing a superior prognosis over the centroblast subtype.
  • Centrocyte subtypes exhibited less resistance to doxorubicin and vincristine, and distinct genetic profiles including TP53 mutations and expression of favorable prognostic genes (LMO2, CD58, MHC class II).

Conclusions:

  • BAGS-based subtyping provides valuable biologic insight into DLBCL heterogeneity.
  • Further development of a BAGS diagnostic platform holds promise for improving DLBCL pathogenetic studies and disease management.